(Q44924621)

7 December 2017

1 reference

title

The blood peptidome: a higher dimension of information content for cancer biomarker discovery (English)

1 reference

7 December 2017

0 references

1 reference

2

1 reference

7 December 2017

3

Robyn P Araujo

1 reference

7 December 2017

4

Lance A Liotta

1 reference

7 December 2017

Emanuel F Petricoin

1

1 reference

7 December 2017

language of work or name

English

0 references

publication date

9 November 2006

1 reference

7 December 2017

published in

Nature Reviews Cancer

1 reference

7 December 2017

volume

6

1 reference

7 December 2017

issue

12

1 reference

7 December 2017

page(s)

961-967

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc2011

7 December 2017

exact match

0 references

cites work

Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?

1 reference

Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems

21 January 2018

1 reference

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

Serum proteomic patterns for detection of prostate cancer

21 January 2018

1 reference

Lessons from Kitty Hawk: from feasibility to routine clinical use for the field of proteomic pattern diagnostics

21 January 2018

1 reference

Clinical proteomics: Written in blood

21 January 2018

1 reference

Characterization of the low molecular weight human serum proteome

21 January 2018

1 reference

Analysis of albumin-associated peptides and proteins from ovarian cancer patients

21 January 2018

1 reference

An investigation into the human serum "interactome"

21 January 2018

1 reference

High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures

21 January 2018

1 reference

Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma.

21 January 2018

1 reference

Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml

21 January 2018

1 reference

Differential exoprotease activities confer tumor-specific serum peptidome patterns

21 January 2018

1 reference

Identification of gastric cancer patients by serum protein profiling

21 January 2018

1 reference

Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry

21 January 2018

1 reference

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

21 January 2018

1 reference

A serum proteomic approach to gauging the state of remission in Wegener's granulomatosis

21 January 2018

1 reference

Peptidomic analysis of breast cancer reveals a putative surrogate marker for estrogen receptor-negative carcinomas

21 January 2018

1 reference

21 January 2018

The peptidomics concept

1 reference

Peptidomics for cancer diagnosis: present and future

21 January 2018

1 reference

The microenvironment of the tumour-host interface

21 January 2018

1 reference

Proteomic analysis of tumor establishment and growth in the B16-F10 mouse melanoma model.

21 January 2018

1 reference

Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression.

21 January 2018

1 reference

Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis.

21 January 2018

1 reference

Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

21 January 2018

1 reference

Biomarker amplification by serum carrier protein binding

21 January 2018

1 reference

Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold

21 January 2018

1 reference

Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer

21 January 2018

1 reference

The human plasma proteome: history, character, and diagnostic prospects

21 January 2018

1 reference

Human Plasma PeptideAtlas

21 January 2018

1 reference

Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identificati

21 January 2018

1 reference

The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome

21 January 2018

1 reference

Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database

21 January 2018

1 reference

Two-dimensional liquid chromatography/tandem mass spectrometry analysis of Gradiflow fractionated native human plasma.

21 January 2018

1 reference

Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers

21 January 2018

1 reference

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

21 January 2018

1 reference

Surface plasmon resonance mass spectrometry: recent progress and outlooks

21 January 2018

1 reference

Physiological occurrence, biosynthesis and metabolism of retinoic acid: evidence for roles of cellular retinol-binding protein (CRBP) and cellular retinoic acid-binding protein (CRABP) in the pathway of retinoic acid homeostasis

21 January 2018

1 reference

Nanoporous surfaces as harvesting agents for mass spectrometric analysis of peptides in human plasma

21 January 2018

1 reference

Selective binding and enrichment for low-molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles

21 January 2018

1 reference

Analysis of human serum by liquid chromatography-mass spectrometry: improved sample preparation and data analysis

21 January 2018

1 reference

Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins

21 January 2018

1 reference

Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma.

21 January 2018

1 reference

Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples

21 January 2018

1 reference

Characterization of the human blood plasma proteome

21 January 2018

1 reference

Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry.

21 January 2018

1 reference

Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

31 March 2020

1 reference

A study of glycoproteins in human serum and plasma reference standards (HUPO) using multilectin affinity chromatography coupled with RPLC-MS/MS

31 March 2020

1 reference

Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers

31 March 2020

1 reference

Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer

31 March 2020

1 reference

Insulin-Like Growth Factor (IGF)-I/IGF-Binding Protein-3 Complex: Therapeutic Efficacy and Mechanism of Protection against Type 1 Diabetes

31 March 2020

1 reference

Effect of immunoaffinity depletion of human serum during proteomic investigations

31 March 2020

1 reference

Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17093504

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17093504

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRC2011

1 reference

7 December 2017

1 reference